These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3829426)

  • 21. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
    Angelin B; Eriksson M; Einarsson K
    Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Bailey KR; Zech LA; Gregg RE; Sprecher DL; Brewer HB
    Am J Cardiol; 1985 May; 55(11):1282-6. PubMed ID: 3887883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM
    Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential use of fenofibrate and other fibric acid derivatives in the clinic.
    Brown WV
    Am J Med; 1987 Nov; 83(5B):85-9. PubMed ID: 3688012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.
    Weisweiler P; Merk W; Janetschek P; Schwandt P
    Atherosclerosis; 1984 Dec; 53(3):321-5. PubMed ID: 6529448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.
    Spengel FA; Jadhav A; Duffield RG; Wood CB; Thompson GR
    Lancet; 1981 Oct; 2(8250):768-70. PubMed ID: 6116902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
    Mabuchi H; Koizumi J; Kajinami K
    Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states.
    Avogaro P; Bittolo Bon G; Belussi F; Pontoglio E; Cazzolato G
    Atherosclerosis; 1983 Apr; 47(1):95-100. PubMed ID: 6870993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
    Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
    An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the addition of fenofibrate to the simvastatin-cholestyramine combination].
    Schlienger JL
    Presse Med; 1991 Mar; 20(12):565. PubMed ID: 1827899
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.
    Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Grundy SM; Knopp RH; Lasser NL; Mellies MJ; Palmer RH; Samuel P
    Arteriosclerosis; 1986; 6(6):670-8. PubMed ID: 3535757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.
    Grundy SM; Vega GL; Bilheimer DW
    Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit.
    Slater HR; Packard CJ; Bicker S; Shepherd J
    J Biol Chem; 1980 Nov; 255(21):10210-3. PubMed ID: 6253466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B.
    Rouffy J; Chanu B; Bakir R; Djian F; Goy-Loeper J
    Atherosclerosis; 1985 Mar; 54(3):273-81. PubMed ID: 3994783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.
    Leitersdorf E; Muratti EN; Eliav O; Meiner V; Eisenberg S; Dann EJ; Sehayek E; Peters TK; Stein Y
    Am J Med; 1994 May; 96(5):401-7. PubMed ID: 8192170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of bezafibrate and of a bezafibrate and cholestyramine combination on lipids and lipoprotein lipids in type IIa hypercholesterolaemic patients.
    Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Res; 1986; 6(3):249-53. PubMed ID: 3744628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III.
    Lussier-Cacan S; Bard JM; Boulet L; Nestruck AC; Grothé AM; Fruchart JC; Davignon J
    Atherosclerosis; 1989 Aug; 78(2-3):167-82. PubMed ID: 2783201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.